|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Synlogic, Inc.
| Synlogic, Inc. 1250 South Capital of Texas Hwy Building 3, Suite 400 Austin, TX 78746 | |
| | Phone: | (512) 901-0900 | Fax: | (512) 681-5201 | Year Established: | 2007 | Ticker: | SYBX | Exchange: | NASDAQ | Main Contact: | Casi DeYoung, CBO | | Other Contacts: | Paul Lammers, President & CEO Alan Fuhrman, CFO
| | Company Description | Synlogic, formerly Mirna, is pioneering the development of a novel class of living treatments, Synthetic BioticTM medicines, based on its proprietary drug development platform. Synlogic's initial pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases, such as Urea Cycle Disorder (UCD) and Phenylketonuria (PKU). In addition, the company is leveraging the broad potential of its platform to create Synthetic Biotic medicines for the treatment of more common diseases, including liver disease, inflammatory and immune disorders, and cancer. Synlogic is collaborating with AbbVie to develop Synthetic Biotic-based treatments for inflammatory bowel disease (IBD). | |
|
|
|
|
|